BEO Therapeutics

Dedicated to develop oral microbiome therapies that counteract diseases caused by modern lifestyle such as gouty arthritis and (cardio-) metabolic diseases

Our unfair advantage

… combining pharmaceutical and nutritional knowledge to the ‘sweet-spot´ between food and pharma…

Beo Therapeutics works selectively with a small fraction of human gut bacteria that are considered safe for human consumption. The bacteria carry the designation Qualified Presumption of Safety (QPS).

Focusing on QPS bacteria has several benefits:

  • QPS approved bacteria can be fast-tracked into human clinical studies under food-supplement regulation (non-IND study). This approach reduces cost and timelines to clinical PoC.
  • QPS products can be commercialised as food-supplements, medical foods or as (non-) prescription drugs. The multiple options reduce product development risk.